COST-EFFECTIVENESS OF A RENAL HEALTH PROGRAM IN PATIENTS WITH HYPERTENSIVE AND/OR DIABETES INDUCED CHRONIC KIDNEY DISEASE

被引:0
|
作者
Rosselli, D. [1 ]
DeAntonio, R. [2 ]
Calderon, C. [1 ]
Sanabria, M. [3 ]
机构
[1] Independiente, Bogota, DC, Colombia
[2] Independent, Bogota, Colombia
[3] Baxter Colombia, Bogota, Cundinamarca, Colombia
关键词
D O I
10.1016/S1098-3015(10)74062-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A200 / A200
页数:1
相关论文
共 50 条
  • [21] Cost-Effectiveness of Empagliflozin in Chronic Kidney Disease with or without Albuminuria
    Odawara, Motoki
    Nishi, Hiroshi
    Kodera, Satoshi
    Kondo, Masahide
    Nangaku, Masaomi
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (01): : 50 - 61
  • [22] COST-EFFECTIVENESS ANALYSIS OF TREATMENTS IN CHRONIC KIDNEY DISEASE IN MEXICO
    Frias Gasga, A. E.
    Cortes-Sanabria, L.
    Rueda Galicia, C.
    Soto, H.
    Guzman Vazquez, S.
    VALUE IN HEALTH, 2022, 25 (07) : S393 - S394
  • [23] Cost-Effectiveness Analysis of Screening Chronic Kidney Disease in Iran
    Ravaghi, Hamid
    Farzaneh, Ali
    Ebrahimnia, Mehdi
    Rostami, Zohreh
    Madani, Mohammad Hasan Hashemi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (11) : IC01 - IC04
  • [24] Cost-Effectiveness of Kidney Transplantation Compared with Chronic Dialysis in End-Stage Renal Disease
    Rosselli, Diego
    Rueda, Juan-David
    Diaz, Carlos Eduardo
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2015, 26 (04) : 733 - 738
  • [25] COST-EFFECTIVENESS OF CANAGLIFLOZIN TREATMENT IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND KIDNEY DISEASE
    Wu, B.
    VALUE IN HEALTH, 2019, 22 : S584 - S584
  • [26] Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis
    Howard, Kirsten
    White, Sarah
    Salkeld, Glenn
    McDonald, Stephen
    Craig, Jonathan C.
    Chadban, Steven
    Cass, Alan
    VALUE IN HEALTH, 2010, 13 (02) : 196 - 208
  • [27] Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes
    Chadban, S.
    Howell, M.
    Twigg, S.
    Thomas, M.
    Jerums, G.
    Cass, A.
    Campbell, D.
    Nicholls, K.
    Tong, A.
    Mangos, G.
    Stack, A.
    MacIsaac, R. J.
    Girgis, S.
    Colagiuri, R.
    Colagiuri, S.
    Craig, J.
    NEPHROLOGY, 2010, 15 : S195 - S203
  • [28] Cost-Effectiveness and Clinical Outcomes of Secondary Hyperparathyroidism Treatments in Patients with Chronic Kidney Disease
    Zhang, Wenjie
    Ren, Hailiang
    Liao, Qianxiu
    Wu, Jian
    CALCIFIED TISSUE INTERNATIONAL, 2024, 114 (04) : 368 - 376
  • [29] Cost-Effectiveness and Clinical Outcomes of Secondary Hyperparathyroidism Treatments in Patients with Chronic Kidney Disease
    Wenjie Zhang
    Hailiang Ren
    Qianxiu Liao
    Jian Wu
    Calcified Tissue International, 2024, 114 : 368 - 376
  • [30] COST-EFFECTIVENESS ANALYSIS OF SUCROFERRIC OXYHYDROXIDE IN TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Ugrekhelidze, D.
    Yagudina, R.
    Kulikov, A.
    VALUE IN HEALTH, 2016, 19 (07) : A518 - A518